Venezuela Approves Probiotic Distribution

The use of the vitamin for calciphylaxis symptoms highlights a new approach with the potential for future treatment options.

In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.

Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?

Shaheen Majeed has been a fixture in the dietary supplement industry, developing a stellar reputation through his leadership at Sabinsa Corp., helping grow the company built by his late father Muhammed Majeed, PhD. Shaheen’s accomplishments at Sabinsa helped modernize and strengthen the company’s brand, serving as a model for the rest of the industry. Now as global CEO and managing director of Sami-Sabinsa Group, Shaheen has the opportunity to apply his vision of the company’s future and build upon his father’s legacy. Nutritional Outlook speaks to Majeed about the personal growth he's experienced in the industry and his goals moving forward for his company.

In the supplemental submission CRN urged FDA to reexamine and correct its interpretation of the drug preclusion clause rather than provide justification for its interpretation

On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”